Hello,
Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and today in healthcare news:
- We got an inside look at biotechs that are using gene-editing to transform medicine;
- What expanding access to high-speed internet means for the future of telehealth;
- 2 people who got COVID-19 after being vaccinated share what to expect from a breakthrough infection.
If you're new to this newsletter, sign up here. Comments, tips? Email me at [email protected] or tweet @lydiaramsey125. Let's get to it…
Investors are betting billions that cutting-edge cures can upend how we treat heart disease and transform pharma
- Gene editing has become one of biotech's hottest advances this year.
- The tech carries the promise of curing diseases with one treatment, upending the drug industry.
- Insider toured some of the leading gene-editing biotech labs and spoke with industry leaders.
The US is helping millions of people get faster internet, and it could shape the next phase of telehealth
- Pandemic subsidies could mean more people can access the internet and telehealth services.
- Experts said it may be a good time for virtual care, though insurance needs to be cemented.
- But there's still more work to ensure equitable broadband and telehealth access, they said.
You will know, or possibly be, someone who gets COVID-19 after a vaccine
- Breakthrough cases will become more common as the more transmissible Delta variant keeps spreading.
- But most disease experts still expect COVID-19 to be milder in vaccinated people.
- Two young people who got sick after they were vaccinated described how their symptoms progressed.
More stories we're reading:
- 8 weeks between shots is the 'sweet spot' for giving Pfizer's two-dose COVID-19 vaccine, UK researchers say (Insider)
- 4 reasons why one science reporter is wearing a mask again (The Atlantic)
- 1 in 5 COVID-19 infections in LA in June were in fully vaccinated people, but most had mild or no symptoms, officials say (Insider)
- Virtual doctors visits may have peaked (Axios)
- Lydia
Read the original article on Business Insider